메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

Author keywords

PLR; Prognostic factor; Prostate cancer; Survival

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

EID: 84969921631     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2363-5     Document Type: Article
Times cited : (33)

References (29)
  • 3
    • 79957957222 scopus 로고    scopus 로고
    • The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation
    • De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schröder F, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol. 2011;60(1):106-17.
    • (2011) Eur Urol , vol.60 , Issue.1 , pp. 106-117
    • Nunzio, C.1    Kramer, G.2    Marberger, M.3    Montironi, R.4    Nelson, W.5    Schröder, F.6
  • 4
    • 84255204457 scopus 로고    scopus 로고
    • Prostate cancer and inflammation: the evidence
    • Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012;60(1):199-215.
    • (2012) Histopathology , vol.60 , Issue.1 , pp. 199-215
    • Sfanos, K.S.1    Marzo, A.M.2
  • 7
    • 84945456801 scopus 로고    scopus 로고
    • Validation of the neutrophil-to lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients
    • Jan 24. [Epub ahead of print]
    • Langsenlehner T, Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Gerger A, et al. Validation of the neutrophil-to lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol. 2015 Jan 24. [Epub ahead of print]
    • (2015) World J Urol.
    • Langsenlehner, T.1    Thurner, E.M.2    Krenn-Pilko, S.3    Langsenlehner, U.4    Stojakovic, T.5    Gerger, A.6
  • 8
    • 84863566526 scopus 로고    scopus 로고
    • Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer
    • Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol. 2012;33(3):749-56.
    • (2012) Tumour Biol , vol.33 , Issue.3 , pp. 749-756
    • Wang, D.S.1    Ren, C.2    Qiu, M.Z.3    Luo, H.Y.4    Wang, Z.Q.5    Zhang, D.S.6
  • 9
    • 84881115045 scopus 로고    scopus 로고
    • Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
    • Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109(2):416-21.
    • (2013) Br J Cancer , vol.109 , Issue.2 , pp. 416-421
    • Stotz, M.1    Gerger, A.2    Eisner, F.3    Szkandera, J.4    Loibner, H.5    Ress, A.L.6
  • 10
    • 82255162065 scopus 로고    scopus 로고
    • Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
    • Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13(7):499-503.
    • (2011) Clin Transl Oncol , vol.13 , Issue.7 , pp. 499-503
    • Asher, V.1    Lee, J.2    Innamaa, A.3    Bali, A.4
  • 11
    • 84860358285 scopus 로고    scopus 로고
    • Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
    • Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17(3):216-22.
    • (2012) Biomarkers , vol.17 , Issue.3 , pp. 216-222
    • Kwon, H.C.1    Kim, S.H.2    Oh, S.Y.3    Lee, S.4    Lee, J.H.5    Choi, H.J.6
  • 12
    • 84892420577 scopus 로고    scopus 로고
    • Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer
    • Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang H, et al. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis. 2013;5(6):783-9.
    • (2013) J Thorac Dis , vol.5 , Issue.6 , pp. 783-789
    • Liu, H.1    Wu, Y.2    Wang, Z.3    Yao, Y.4    Chen, F.5    Zhang, H.6
  • 13
    • 84867583029 scopus 로고    scopus 로고
    • A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)
    • Pinato DJ, Stebbing J, Ishizuka M, Khan SA, Wasan HS, North BV, et al. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol. 2012;57(5):1013-20.
    • (2012) J Hepatol , vol.57 , Issue.5 , pp. 1013-1020
    • Pinato, D.J.1    Stebbing, J.2    Ishizuka, M.3    Khan, S.A.4    Wasan, H.S.5    North, B.V.6
  • 14
    • 84880314507 scopus 로고    scopus 로고
    • Markers of systemic inflammation predict survival in patients with advanced renal cell cancer
    • Fox P, Hudson M, Brown C, Lord S, Gebski V, De Souza P, et al. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer. 2013;109(1):147-53.
    • (2013) Br J Cancer , vol.109 , Issue.1 , pp. 147-153
    • Fox, P.1    Hudson, M.2    Brown, C.3    Lord, S.4    Gebski, V.5    Souza, P.6
  • 15
    • 80051554435 scopus 로고    scopus 로고
    • Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of esophageal cancer
    • Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of esophageal cancer. World J Surg. 2011;35(8):1861-6.
    • (2011) World J Surg , vol.35 , Issue.8 , pp. 1861-1866
    • Dutta, S.1    Crumley, A.B.2    Fullarton, G.M.3    Horgan, P.G.4    McMillan, D.C.5
  • 16
    • 84931045121 scopus 로고    scopus 로고
    • Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
    • Kaynar M, Yildirim ME, Gul M, Kilic O, Ceylan K, Goktas S. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio. Cancer Biomark. 2015;15(3):317-23.
    • (2015) Cancer Biomark , vol.15 , Issue.3 , pp. 317-323
    • Kaynar, M.1    Yildirim, M.E.2    Gul, M.3    Kilic, O.4    Ceylan, K.5    Goktas, S.6
  • 17
    • 84944474807 scopus 로고    scopus 로고
    • Predictive value of the platelet-to-lymphocyte ratio in diagnosis of prostate cancer
    • Yuksel OH, Urkmez A, Akan S, Yldirim C, Verit A. Predictive value of the platelet-to-lymphocyte ratio in diagnosis of prostate cancer. Asian Pac J Cancer Prev. 2015;16(15):6407-12.
    • (2015) Asian Pac J Cancer Prev , vol.16 , Issue.15 , pp. 6407-6412
    • Yuksel, O.H.1    Urkmez, A.2    Akan, S.3    Yldirim, C.4    Verit, A.5
  • 18
    • 84929282302 scopus 로고    scopus 로고
    • Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy
    • 201.e9-16
    • Langsenlehner T, Pichler M, Thurner EM, Krenn-Pilko S, Stojakovic T, Gerger A, et al. Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy. Urol Oncol. 2015;33(5):201.e9-16.
    • (2015) Urol Oncol , vol.33 , Issue.5
    • Langsenlehner, T.1    Pichler, M.2    Thurner, E.M.3    Krenn-Pilko, S.4    Stojakovic, T.5    Gerger, A.6
  • 19
    • 84888815889 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013
    • Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124-37.
    • (2014) Eur Urol , vol.65 , Issue.1 , pp. 124-137
    • Heidenreich, A.1    Bastian, P.J.2    Bellmunt, J.3    Bolla, M.4    Joniau, S.5    Kwast, T.6
  • 20
    • 84891809097 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. part II: Treatment of advanced, relapsing, and castration-resistant prostatecancer
    • Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part II: Treatment of advanced, relapsing, and castration-resistant prostatecancer. Eur Urol. 2014;65(2):467-79.
    • (2014) Eur Urol , vol.65 , Issue.2 , pp. 467-479
    • Heidenreich, A.1    Bastian, P.J.2    Bellmunt, J.3    Bolla, M.4    Joniau, S.5    Kwast, T.6
  • 21
    • 15244343497 scopus 로고    scopus 로고
    • Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
    • Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J, et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest. 2004;114(12):1714-25.
    • (2004) J Clin Invest , vol.114 , Issue.12 , pp. 1714-1725
    • Boucharaba, A.1    Serre, C.M.2    Gres, S.3    Saulnier-Blache, J.S.4    Bordet, J.C.5    Guglielmi, J.6
  • 22
    • 62449209166 scopus 로고    scopus 로고
    • Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production
    • Dashevsky O, Varon D, Brill A. Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer. 2009;124(8):1773-7.
    • (2009) Int J Cancer , vol.124 , Issue.8 , pp. 1773-1777
    • Dashevsky, O.1    Varon, D.2    Brill, A.3
  • 23
    • 65349136963 scopus 로고    scopus 로고
    • Platelets and fibeinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity
    • Zheng S, Shen J, Jiao Y, Liu Y, Zhang C, Wei M, et al. Platelets and fibeinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci. 2009;100(5):859-65.
    • (2009) Cancer Sci , vol.100 , Issue.5 , pp. 859-865
    • Zheng, S.1    Shen, J.2    Jiao, Y.3    Liu, Y.4    Zhang, C.5    Wei, M.6
  • 24
    • 4143141823 scopus 로고    scopus 로고
    • The immunobiology of cancer immunosurveillance and immunoediting
    • Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137-48.
    • (2004) Immunity , vol.21 , Issue.2 , pp. 137-148
    • Dunn, G.P.1    Old, L.J.2    Schreiber, R.D.3
  • 25
    • 84922487903 scopus 로고    scopus 로고
    • Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
    • Huang SH, Waldron JN, Milosevic M, Shen X, Ringash J, Su J, et al. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer. 2015;121(4):545-55.
    • (2015) Cancer , vol.121 , Issue.4 , pp. 545-555
    • Huang, S.H.1    Waldron, J.N.2    Milosevic, M.3    Shen, X.4    Ringash, J.5    Su, J.6
  • 26
    • 84907198355 scopus 로고    scopus 로고
    • Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
    • Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, et al. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol. 2014;32(27):2959-66.
    • (2014) J Clin Oncol , vol.32 , Issue.27 , pp. 2959-2966
    • Adams, S.1    Gray, R.J.2    Demaria, S.3    Goldstein, L.4    Perez, E.A.5    Shulman, L.N.6
  • 27
    • 84903381441 scopus 로고    scopus 로고
    • Prognostic value of PLR in various cancers: a meta-analysis
    • Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9(6), e101119.
    • (2014) PLoS One , vol.9 , Issue.6
    • Zhou, X.1    Du, Y.2    Huang, Z.3    Xu, J.4    Qiu, T.5    Wang, J.6
  • 29
    • 84940676445 scopus 로고    scopus 로고
    • Platelet to lymphocyte ratio plays an important role in prostate cancer's diagnosis and prognosis
    • Li F, Hu HB, Gu S, Chen X, Sun Q. Platelet to lymphocyte ratio plays an important role in prostate cancer's diagnosis and prognosis. Int J Clin Exp Med. 2015;8(7):11746-51.
    • (2015) Int J Clin Exp Med , vol.8 , Issue.7 , pp. 11746-11751
    • Li, F.1    Hu, H.B.2    Gu, S.3    Chen, X.4    Sun, Q.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.